Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Scordo

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|February 18, 2014
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignanciesCraig S Sauter, Joanne F Chou, Esperanza B Papadopoulos, et al.
Blood Advances|August 21, 2024
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphomaKathryn R Tringale, Michael Scordo, Joachim Yahalom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2020
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationMariam T Nawas, Heather J Landau, Craig S Sauter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell TransplantationMichael Scordo, Sejal M Morjaria, Eric R Littmann, et al.
Blood Advances|August 17, 2022
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantationMariam T Nawas, Miriam Sanchez-Escamilla, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2016
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide ConditioningMichael Scordo, Valkal Bhatt, Meier Hsu, et al.
Open Forum Infectious Diseases|April 21, 2016
Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer CenterSejal Morjaria, David J Epstein, Fabian A Romero, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 4, 2019
Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometryRyan C Schofield, Heather J Landau, Sergio A Giralt, et al.
Cytotherapy|November 5, 2025
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantationYeon Joo Lee, Yuxuan Li, Michael Scordo, et al.
Bone Marrow Transplantation|June 15, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantationKristian Casem, Stephanie Monaco-Cermak, Andrew Lin, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|February 18, 2014
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignanciesCraig S Sauter, Joanne F Chou, Esperanza B Papadopoulos, et al.
Blood Advances|August 21, 2024
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphomaKathryn R Tringale, Michael Scordo, Joachim Yahalom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 20, 2020
Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationMariam T Nawas, Heather J Landau, Craig S Sauter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2018
Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell TransplantationMichael Scordo, Sejal M Morjaria, Eric R Littmann, et al.
Blood Advances|August 17, 2022
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantationMariam T Nawas, Miriam Sanchez-Escamilla, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2016
A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide ConditioningMichael Scordo, Valkal Bhatt, Meier Hsu, et al.
Open Forum Infectious Diseases|April 21, 2016
Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer CenterSejal Morjaria, David J Epstein, Fabian A Romero, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 4, 2019
Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometryRyan C Schofield, Heather J Landau, Sergio A Giralt, et al.
Cytotherapy|November 5, 2025
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantationYeon Joo Lee, Yuxuan Li, Michael Scordo, et al.
Bone Marrow Transplantation|June 15, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantationKristian Casem, Stephanie Monaco-Cermak, Andrew Lin, et al.
Pageof 18